COL1A2 and hereditary sensory and autonomic neuropathy: Western blot analysis revealed that the levels of CD133, integrin β1, and ALDH1A1 were significantly increased in response to CIP treatment in a dose-dependent manner, whereas the expression of procollagen type I was significantly suppressed (Figure 5(c)).